Date: 2015-12-17
Type of information: Production agreement
Compound: undisclosed product
Company: BioInvent (Sweden) undisclosed major global pharmaceutical company
Therapeutic area: Technology - Services
Type agreement: production manufacturing
Action mechanism:
Disease:
Details: * On December 17, 2015, BioInvent International announced that the company has been selected by a major global pharmaceutical company to provide manufacturing services for one of the products in the pharmaceutical company’s development portfolio. The agreement is expected to generate about SEK 25 million in revenue over the next three quarters, with the possibility for additional activities as the project progresses.
Terms and the pharmaceutical company were not disclosed, but the agreement includes payments for manufacturing and providing services such as quality assurance.
Financial terms:
Latest news:
